Literature DB >> 9643686

Role of human-milk lactadherin in protection against symptomatic rotavirus infection.

D S Newburg1, J A Peterson, G M Ruiz-Palacios, D O Matson, A L Morrow, J Shults, M L Guerrero, P Chaturvedi, S O Newburg, C D Scallan, M R Taylor, R L Ceriani, L K Pickering.   

Abstract

BACKGROUND: Human milk contains a 46 kDa mucin-associated glycoprotein, lactadherin, which binds specifically to rotavirus and inhibits its replication. This study tested the hypothesis that lactadherin protects against symptoms of rotavirus infection.
METHODS: 200 infants in Mexico City were recruited at birth and monitored by regular stool EIA for rotavirus, serology, and recording of feeding and stool patterns. Milk samples were obtained from the mothers weekly until 4 weeks post partum then monthly. The sample taken immediately before an infant's episode of rotavirus infection was assayed for lactadherin, butyrophilin, mucin, and secretory IgA. An infection was defined as symptomatic if diarrhoea occurred in the 5 days before or after detection of the virus.
FINDINGS: 31 infants developed rotavirus infection; 15 were symptomatic and 16 had no symptoms. The median concentration of lactadherin in the milk samples (obtained 4-41 days [median 13] before the infection) was 48.4 (range 5.6-180) microg/mL in the asymptomatic group and 29-2 (6.2-103-4) microg/mL in the symptomatic group. Although these medians did not differ significantly, in logistic regression analysis adjusted for age at infection and secretory IgA concentration there was a significant difference between the groups (p=0O01). No association between symptom status and concentrations of butyrophilin, mucin, or secretory IgA was found.
INTERPRETATION: Protection against rotavirus by human milk is associated with the glycoprotein lactadherin. This association is independent of products of the secretory immune system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9643686     DOI: 10.1016/s0140-6736(97)10322-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  63 in total

1.  Using cognitive-behavioural techniques to improve exclusive breastfeeding in a low-literacy disadvantaged population.

Authors:  Atif Rahman; Zaeem Haq; Siham Sikander; Ikhlaq Ahmad; Mansoor Ahmad; Assad Hafeez
Journal:  Matern Child Nutr       Date:  2011-11-08       Impact factor: 3.092

2.  Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.

Authors:  Penelope M Drake; Birgit Schilling; Richard K Niles; Akraporn Prakobphol; Bensheng Li; Kwanyoung Jung; Wonryeon Cho; Miles Braten; Halina D Inerowicz; Katherine Williams; Matthew Albertolle; Jason M Held; Demetris Iacovides; Dylan J Sorensen; Obi L Griffith; Eric Johansen; Anna M Zawadzka; Michael P Cusack; Simon Allen; Matthew Gormley; Steven C Hall; H Ewa Witkowska; Joe W Gray; Fred Regnier; Bradford W Gibson; Susan J Fisher
Journal:  J Proteome Res       Date:  2012-03-13       Impact factor: 4.466

3.  Identification of Escherichia coli F4ac-binding proteins in porcine milk fat globule membrane.

Authors:  Predrag Novakovic; Yanyun Y Huang; Betty Lockerbie; Farshid Shahriar; John Kelly; John R Gordon; Dorothy M Middleton; Matthew E Loewen; Beverly A Kidney; Elemir Simko
Journal:  Can J Vet Res       Date:  2015-04       Impact factor: 1.310

4.  Milk Oligosaccharides Inhibit Human Rotavirus Infectivity in MA104 Cells.

Authors:  Daniel R Laucirica; Vassilis Triantis; Ruud Schoemaker; Mary K Estes; Sasirekha Ramani
Journal:  J Nutr       Date:  2017-06-21       Impact factor: 4.798

5.  Influence of breastfeeding versus formula feeding on lymphocyte subsets in infants at risk of coeliac disease: the PROFICEL study.

Authors:  Tamara Pozo-Rubio; Amalia Capilla; Jorge R Mujico; Giada de Palma; Ascensión Marcos; Yolanda Sanz; Isabel Polanco; Maria Dolores García-Novo; Gemma Castillejo; Carmen Ribes-Koninckx; Vicente Varea; Francesc Palau; Luis Ortigosa; Luis Peña-Quintana; Esther Nova
Journal:  Eur J Nutr       Date:  2012-05-11       Impact factor: 5.614

Review 6.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

7.  Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi.

Authors:  Charles van der Horst; Charles Chasela; Yusuf Ahmed; Irving Hoffman; Mina Hosseinipour; Rodney Knight; Susan Fiscus; Michael Hudgens; Peter Kazembe; Margaret Bentley; Linda Adair; Ellen Piwoz; Francis Martinson; Ann Duerr; Athena Kourtis; A Edde Loeliger; Beth Tohill; Sascha Ellington; Denise Jamieson
Journal:  Contemp Clin Trials       Date:  2008-09-07       Impact factor: 2.226

8.  Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.

Authors:  Zhiliang Wu; Thidarut Boonmars; Isao Nagano; Watcharin Loilome; Puangrat Yongvanit; Narong Khuntikeo; Phuangphaka Sadee Nielsen; Chawalit Paorojkul; Yuzo Takahashi; Yoichi Maekawa
Journal:  Tumour Biol       Date:  2014-03

9.  Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries.

Authors:  Sung-Sil Moon; Jacqueline E Tate; Pratima Ray; Penelope H Dennehy; Derseree Archary; Anna Coutsoudis; Ruth Bland; Marie-Louise Newell; Roger I Glass; Umesh Parashar; Baoming Jiang
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

10.  The mouse gamete adhesin, SED1, is expressed on the surface of acrosome-intact human sperm.

Authors:  Susannah D Copland; Ana A Murphy; Barry D Shur
Journal:  Fertil Steril       Date:  2008-11-05       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.